Normal specification of the extraembryonic lineage after somatic nuclear transfer  by Kishigami, Satoshi et al.
FEBS Letters 580 (2006) 1801–1806Normal speciﬁcation of the extraembryonic lineage after somatic
nuclear transfer
Satoshi Kishigami*, Takafusa Hikichi, Nguyen Van Thuan, Hiroshi Ohta, Sayaka Wakayama,
Hong-Thuy Bui, Eiji Mizutani, Teruhiko Wakayama
Laboratory for Genomic Reprogramming, Center for Developmental Biology RIKEN Kobe, 2-2-3 Minatojima-minamimachi, Kobe 650-0047, Japan
Received 13 December 2005; revised 30 January 2006; accepted 15 February 2006
Available online 24 February 2006
Edited by Michael R. BubbAbstract To examine the establishment and maintenance of
trophectoderm (TE) lineage in somatic cloned blastocysts, the
expression of Cdx2, a key molecule for speciﬁcation of TE fate,
was immunohistochemically examined simultaneously with Oct4
expression. Cloned mouse embryos were made by nuclear trans-
fer using cumulus cells, tail-tip ﬁbroblasts, and embryonic stem
cells. After 96 h of culture, the rates of Oct4-expressing blasto-
cysts were as low as 50% and 60% for cumulus and ﬁbroblast
clones, respectively. However, regardless of Oct4 expression,
the majority of those cloned blastocysts (>90%) normally ex-
pressed Cdx2. Thus, even though somatic cloned embryos have
reduced potential to produce the inner cell mass lineage, the
TE lineage can be established and maintained.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Oct41. Introduction
The success of somatic cell cloning in the mouse gives prom-
ise to applications such as species preservation, livestock prop-
agation, and cell therapy for medical treatment by nuclear
transfer embryonic stem (NT-ES) cells [1–4]. However, cloning
by somatic cell nuclear transfer (SCNT) is still ineﬃcient. Dur-
ing development, a signiﬁcant number of cloned embryos die
during the pre- and peri-implantation period [5]. This early
stage lethality may represent a potential problem when estab-
lishing either or both embryonic and extraembryonic lineages
within the developing embryo.
Blastocysts are composed of the inner cell mass (ICM) that
will form the embryo proper, and the trophectoderm (TE) that
forms the trophoblast lineage for the future placenta. The
molecular mechanism underlying the initial establishment of
the TE and ICM lineages has been elusive. Oct4 (Pou5f1-
Mouse Genome Informatics) encodes a POU-domain tran-
scription factor which is required for maintenance of the
ICM as well as pluripotency of ES cells [6,7]. By the morula
stage, Oct4 is expressed in all blastomeres. But, after initiation
of blastocyst formation, Oct4 becomes restricted to the ICM*Corresponding author. Fax: +81 78 306 3095.
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doi:10.1016/j.febslet.2006.02.036and downregulated in the TE [8,9]. Since Oct4-deﬁcient em-
bryos fail to form the pluripotent ICM, it can be surmised that
embryos require Oct4 for establishment of the normal ICM as
well as its maintenance [6]. Further, conditional repression of
Oct4 in ES cells leads to induction of TE markers including
Cdx2 [7,10]. Cdx2, a caudal-type homeodomain transcription
factor, is the earliest transcription factor to be involved in
speciﬁcation of TE fate expressing at the morula stage and
then restricted to the TE at the blastocyst stage [9,11]. Homo-
zygous mutant Cdx2 embryos fail to maintain the blastocoel,
have reduced expression of TE markers including Eomes and
then, die around the time of implantation [11,12]. Further,
Cdx2 mutant blastocysts exhibit the expanded expression of
Oct4 and Nanog in the presumptive TE. Together with these
ﬁndings, the recent accumulating evidence strongly suggest
that Oct4 and Cdx2 are mutually inhibitory either directly or
indirectly [13,14] and indicate that these two genes are not only
the lineage markers but also essential for the establishment and
maintenance of the ICM and TE lineages at the blastocyst
stage.
In somatic cloned blastocysts, Oct4 is often downregulated
or abnormally expressed in presumptive TE cells, suggesting
the loss of or reduced pluripotency in the ICM lineage in
cloned embryos [15–17]. However, it has not been well exam-
ined how normally the extraembryonic lineage is established
and maintained in somatic cloned embryos in the presence
of the abnormal ICM lineage. Therefore, using anti-Cdx2
and anti-Oct4 antibodies we address how normally somatic
cloned blastocysts establish and maintain the extraembryonic
lineage with emphasis on the spatial patterning of Cdx2
expression.2. Materials and methods
2.1. Animals
B6D2F1 mice (C57BL/6 ·DBA/2) were used to prepare oocyte and
somatic-cell (cumulus or ﬁbroblast cells) donors as well as spermato-
zoa.2.2. Cloned embryos by using adult somatic cells and microinsemination
(ICSI)
Nuclear transfer was performed as described [18]. Enucleated
B6D2F1 oocytes were injected individually with an adult tail-tip,
cumulus cell, or ES cell (E14) nuclei [18–20]. After nuclear transfer,
the reconstructed oocytes were activated by Sr2+ and cultured for 4
days in KSOM medium. Collection of spermatozoa as well as ICSI
was performed according to previously described methods [21].blished by Elsevier B.V. All rights reserved.
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All donor cells were ﬁxed after plating except cumulus cells which
were ﬁxed by direct suspension in 4% paraformaldehyde. Fertilized
embryos used as controls were made by ICSI and cultured in KSOM
until 3.5 dpc and then ﬁxed following attachment and outgrowth of
3 days after plating in DMEM containing 20% FCS.
For analysis of expanded blastocysts, following oocyte activation
after nuclear transfer or ICSI, embryos were cultured for 96 h.
Either expanding or expanded blastocysts with more than 20 cells
were ﬁxed overnight at 4 C in phosphate-buﬀered saline containing
4% paraformaldehyde. The following process is as described previ-
ously [22]. Primary antibodies against Oct4 (H-134, Santa Cruz Bio-
technology, CA, USA) and Cdx2 (CDX2-88, BioGenex, CA, USA),
were used.2.4. RT-PCR analysis
RT-PCR reactions to detect Oct4, Cdx2, and Hprt were performed
basically following the previous report [23] with small changes in
cDNA preparation and the use of Taq DNA polymerase. Total
RNA from either culture cells or individual blastocysts was prepared
using RNeasy Protect Mini Kit (Qiagen) and was reverse transcribed
using Superscript III First-Strand Synthesis System (Invitrogen). Ex
Taq Hot Start version (Takara, Shiga, Japan) was used in the PCR
reactions.2.5. Statistical analyses
Proportions were compared by a simple two-tailed z test not requir-
ing the square root and arc sin transformation.Fig. 1. Oct4 and Cdx2 expression in donor cell lines. Cumulus (A–A000), ﬁbro
and -Cdx2 antibodies. Oct4 expressed only in ES cells. None of these cell l
stained as control for these two antibodies. Oct4 and Cdx2 stained the ICM a
on cumulus, ﬁbroblast, and ES cells as well as fertilized E4.5 embryos as con
Oct4 and Cdx2 analyzed by RT-PCR were consistent with the staining resu3. Results and discussion
3.1. Oct4 and Cdx2 expression in donor cells
Donor cells from adult mice as well as ES cells were immuno-
stained with antibodies against Oct4 and Cdx2. Neither Oct4 nor
Cdx2 expression was detected in two types of somatic cells,
cumulus cells and ﬁbroblasts (Fig. 1A and B), which is consistent
with previous reports: in the adult, the expression ofOct4 and its
related genes are excluded from the somatic tissues [16,24] and
Cdx2 expression is conﬁned to the intestinal epithelium [25]. In
control experiments, as expected, ES cells expressed Oct4 but
not Cdx2 (Fig. 1C) and an attached ICSI blastocyst expressed
both Oct4 and Cdx2 appropriately (Fig. 1D). These immunohis-
tochemical data were also conﬁrmed by RT-PCR analysis
(Fig. 1E). Thus, these two genes were discernibly silent in these
somatic donor cells, that is, before nuclear transfer. Although
Oct4 should start to express earlier than Cdx2 [11,13,26], both
genes in the donor cells have to somehow be reactivated before
blastocyst formation and after nuclear transfer for normal spec-
iﬁcation of embryonic and extraembryonic lineages.
3.2. Oct4 and Cdx2 expression in blastocysts cloned from
somatic cells
At 96 h after oocyte activation following nuclear transfer,
cloned blastocysts from cumulus and ﬁbroblast cells (n = 54blast (B–B000), and ES (C–C000) cells were doubly stained with anti-Oct4
ines expressed Cdx2. Fertilized embryos grown in vitro (D–D000) were
nd trophoblast giant cells, respectively. Scale bar = 50 lm. (E) RT-PCR
trol to detect marker gene expression. The gene expression patterns of
lts by their speciﬁc antibodies.
Table 1
Classiﬁcation of embryos by Oct4 and Cdx2 expression
Pattern types Type I Type II Type III Type IV Total no.
Oct4 Normal Low Normal Low
Cdx2 Normal Normal Low Low
No. cumulus clone (%) 27 (50)a 23 (43)a 0 (0) 4 (7)a 54
No. ﬁbroblast clone (%) 25 (60)a 17 (41)a 0 (0) 0 (0)a 42
No. ES clone (%) 50 (78)b 3 (5)b 7 (11)a 4 (6)a 64
No. ICSI blast (%) 76 (84)b 6 (7)b 5 (6)a 4 (4)a 91
Within the same column, values with diﬀerent superscripts are signiﬁcantly diﬀerent (P < 0.05).
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of Oct4 and Cdx2. In this study, all the blastocysts were clas-
siﬁed into four types, type I–type IV, according to the combi-
nations of their expression levels (Table 1). Almost half of the
cumulus and ﬁbroblast clones (50% and 60%, respectively)
showed that both Oct4 and Cdx2 expression patterns and were
classiﬁed as type I (Fig. 2A and D). However, it is noted that a
signiﬁcant number of type I blastocysts showed aberrant Oct4
expression patterning in a non-restricted manner to the ICM
as described later. Therefore, not all but only some of these
type I clones are expected to develop successfully following
implantation. In type II cloned blastocysts, a normal level of
Cdx2 but none or low level of Oct4 was observed (Fig. 2B
and E), suggesting the presence of TE lineage and a lack of
ICM lineage. These type II blastocysts (43% and 40%, respec-
tively, for cumulus and ﬁbroblast clones) are not likely to
develop further as seen in Oct4-deﬁcient embryos [6]. Interest-
ingly, there were no type III somatic cloned blastocysts which
should have normal Oct4 expression and low expression of
Cdx2. Finally, only a few type IV cloned blastocysts (7% and
0%) were found, in which both Oct4 and Cdx2 were hardly
detected (Fig. 2C). Thus, more than 90% of the somatic clones
fell into either type I or II, both of which express Cdx2 (Table
1). In contrast, the number of Oct4-expressing somatic clones
as included into either type I or III was only around half,
suggesting normal establishment and maintenance of TE line-
age in most somatic clones but diﬃculty in establishment and
maintenance of ICM lineages. These immunohistochemical
data for cumulus clones were also conﬁrmed by RT-PCR
analysis (Fig. 2F). Therefore, most of the somatic cloned
blastocysts have the ability to produce the extraembryonic
lineage regardless of failure to establish or maintain the
embryonic lineage at the blastocyst stage.
3.3. Blastocysts cloned from embryonic stem cells vs. somatic
cells
ES cloned blastocysts were examined as well as embryos fer-
tilized by ICSI (n = 64 and 91, respectively) in the same man-
ner as the somatic clones. As expected, a greater number of
type I blastocysts were found in ES clones as well as ICSI con-
trol embryos (78% and 83%, respectively, for ES clones and
ICSI control). Type II (5% and 7%) and IV (6% and 4%) blas-
tocysts were very limited. Interestingly, a minor but signiﬁcant
amount of type III blastocysts were found from ES clones and
ICSI embryos (11% and 6%, respectively) (Fig. 3A–D). Thus,
about 80% of cloned blastocysts from ES cells normally ex-
pressed both Oct4 and Cdx2 as well as fertilized embryos, in
agreement with previous reports of Oct4 expression in ESclones [15–17]. Taken together with the results for the somatic
clones, the majority of cloned blastocysts belong to either type
I or II, suggesting the successful reactivation of Cdx2 in most
clones is likely and yet independent of donor cell type but the
eﬃciency of successful reactivation of Oct4 depends on origins
of the donor nuclei (Table 1). Recently it is suggested that Oct4
expression is diﬀerently regulated, depending on the develop-
mental stages and cell types, by the diﬀerent epigenetic statuses
of the Oct4 gene including DNA-methylation and chromatin
remodeling [27]. Therefore, this dependency of Oct4 reactiva-
tion on donor cells in cloned embryos may reﬂect the epige-
netic status of Oct4 in each donor cell type.
3.4. Non-restricted expression of Oct4 in cloned embryos
Oct4 expression patterning in the ICM is often disturbed in
cloned embryos [15,17]. We also found cloned blastocysts in
which Oct4-positive cells were not restricted to the ICM region
regardless of donor cell type (Fig. 4B). Next, we examined the
frequency of this disturbance among type I cloned embryos. A
signiﬁcantly lower number of Oct4-restricted expressing blas-
tocysts (41% and 64% for cumulus and ﬁbroblast clones,
respectively) was observed after somatic nuclear transfer
(Fig. 4C). In contrast, ES clones and fertilized embryos
showed a high percentage of Oct4-restricted expression pat-
terns (87% and 86%, respectively). Thus, not only are Oct4
expression levels but also the patterning unique to individual
donor cell types. Importantly, regardless of restriction of
Oct4 expression, Cdx2 was normally expressed in almost all
the presumptive TE cells (Fig. 4B). Actually, in more than
90% of Oct4 expressing cells in presumptive TE cells of
‘‘non-restricted’’ cloned blastocysts, Cdx2 expression was also
more or less maintained (Fig. 4B, arrows), suggesting an
abnormal gene regulation of Oct4 and Cdx2 in presumptive
TE cells as well as a compromised or delayed lineage determi-
nation which would prevent normal embryonic development.
However, this abnormal Oct4 co-expression with Cdx2 in pre-
sumptive TE cells is not expected to be maintained long-term
because of mutual inhibition between Oct4 and Cdx2 [13,14].
Actually, when cumulus clones with such non-restricted Oct4
expression are cultured for outgrowth formation, half lack
Oct4-expressing cells [15], suggesting the inactivation of Oct4
expression by Cdx2 in subsequent culturing.
In this study, we have revealed that most cloned blastocysts
regardless of donor origin, express Cdx2 normally despite loss
or aberrancy of Oct4 expression, suggesting a capability of
clones to reactivate Cdx2 and to correctly specify the extraem-
bryonic lineage, even when Oct4 expression occurs simulta-
neously in presumptive TE cells. Therefore, it is likely that
Fig. 2. Oct4 and Cdx2 expression patterns in the somatic cloned blastocysts. Blastocysts cloned from cumulus (A–C) or ﬁbroblast (D, E) cells
were doubly stained with antibodies against Oct4 (green) and Cdx2 (red). Those blastocysts were classiﬁed as four types (type I–type IV) as shown
in Table 1 according to the protein level of Oct4 and Cdx2. Type I (A–A000 and D–D000) expressed both Oct4 and Cdx2. In type II cloned
blastocysts (B–B000 and E–E000), Cdx2 expression was normal but Oct4 was nearly undetected. There were no type III somatic cloned blastocysts
found in which only Oct4 is highly expressed while Cdx2 expression is low. Type IV blastocysts show low expression of both Oct4 and Cdx2.
Scale bar = 25 lm. (F) Representative examples of RT-PCR on individual E4.5 blastocysts cloned from cumulus cells. Classiﬁcation of 16
embryos based on Oct4 and Cdx2 expression as well as the rates for each type which are comparable to those by immunohistochemical analysis
shown in Table 1.
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inappropriately expressed which would reﬂect a total failure
of reprogramming itself. In other words, in somatic clones,
individual genes essential for embryonic development, are
not expected to be concurrently reprogrammed but rather
diﬀerently, which may represent diﬀerent mechanisms in repro-
gramming of these individual genes after SCNT like DNA-methylation and chromatin remodeling dependent [27] and
independent mechanisms.
Although cloned mice routinely show abnormal non-lethal
placental development [19,28], placentas alone are often found
in the absence of an embryo proper at full term [20,29,30], con-
sistent with our ﬁnding that the extraembryonic lineage is
established and maintained in most somatic clones. Our ﬁnd-
Fig. 3. Oct4 and Cdx2 expression patterns in ES clones and fertilized embryos. (A, B) Oct4 and Cdx2 expression in blastocysts cloned from ES cells.
Blastocysts cloned from ES cells (A, B) and fertilized embryos (C, D) were doubly stained with antibodies against Oct4 (green) and Cdx2 (red).
Among ES clones or fertilized embryos, we found type III embryos which highly express Oct4 but minimally express Cdx2. Scale bar = 25 lm.
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rates of trophoblast stem cells [31] even from cloned blasto-
cysts (NT-TS cells) should be comparable to those from fertil-Fig. 4. Oct4 restricted and non-restricted expressions in clones. Even when Oc
somatic clones. Oct4-positive cells were not always restricted to the ICM but
also Cdx2-positive (arrows). Scale bar = 25 lm. (C) The rates of restrictionized blastocysts unlike the establishment of NT-ES cells. Thus,
our ﬁndings provide insight into both the reprogramming of
somatic nuclei and embryonic development of somatic clones.t4 is highly expressed, the expression pattern was often abnormal in the
rather dispersed among the TE cells (B–B000). Mostly, those cells were
of Oct4 positive cells were dependent upon the donor cell lines.
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